Traditional machine learning often struggles with limited or incomplete medical data. Our quantum-inspired approach excels at identifying patterns in sparse, complex datasets, providing more accurate diagnoses that adapt to patient variability.
Our novel machine learning paradigm outperforms traditional methods for detecting morphology-predicted large-scale transitions in circulating tumor cells using quantum cognition. Our technology excels at finding patterns in complex morphological data.
Our QCML technology achieved superior results in predicting ER+/- tumors for breast cancer patients using only 70 patients and 129 features, outperforming traditional analysis with the same limited dataset.
With urinalysis data from 1,436 patients, our QCML model achieved a precision of 0.64 and AUC of 0.84, outperforming Logistic Regression, Random Forest, XGBoost, and Neural Networks in UTI prediction.
Our QCML Autoencoder can process images with up to 90% of pixels randomly masked, still delivering accurate diagnostics when fed to a neural network - a capability especially valuable in medical imaging.
QCML requires fewer computing resources and smaller datasets than traditional approaches while delivering better results. This makes our technology cost-effective for medical applications with limited patient data.
As noted by a collaborating medical testing company:
"Your analysis was more performant than ours. ...The features that your model weighted as more relevant to the prediction made real biological sense."